DFS
60
4
GME
57
2
PFG
36
3
DGX
36
3
GILD
62
2
THC
67
2
KMX
55
9
COST
54
4
BK
69
4
KMI
69
4
XYL
35
4
TRV
48
2
DTE
49
2
AON
49
2
HCA
53
3
AVY
53
3
VMC
62
5
NUE
51
3
PX
66
4
DD
64
9
DFS
60
4
GME
57
2
PFG
36
3
DGX
36
3
GILD
62
2
THC
67
2
KMX
55
9
COST
54
4
BK
69
4
KMI
69
4
XYL
35
4
TRV
48
2
DTE
49
2
AON
49
2
HCA
53
3
AVY
53
3
VMC
62
5
NUE
51
3
PX
66
4
DD
64
9
Financhill
Back

TG Therapeutics Stock Predictions

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
60

TGTX
TG Therapeutics

Last Price:
25.85
Seasonality Move:
21.95%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

TG Therapeutics Stock Forecast

  • Over the next 52 weeks, TG Therapeutics has on average historically risen by 26.7% based on the past 28 years of stock performance.
  • TG Therapeutics has risen higher in 15 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.57%
  • Is TG Therapeutics Stock Undervalued?
    The current TG Therapeutics [TGTX] share price is $25.86. The Score for TGTX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • TGTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will TG Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, TG Therapeutics has on average historically risen by 26.7% based on the past 28 years of stock performance.

TG Therapeutics Stock Rating

Buy
60
TG Therapeutics (TGTX) is a Buy

Is TG Therapeutics overpriced?

  • TG Therapeutics has risen higher in 15 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.57%

TG Therapeutics Stock Price History

Is TGTX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TGTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tgtherapeutics.com

52-Week Data

52-Week High:
26.99
52-Week Low:
9.81

Prediction Charts

Market Cap:
4B
Price in USD:
25.86
Volume:
3.95M
Beta:
0.95

Technical Analysis

SMA50:
23.56
SMA100:
21.80
SMA200:
18.69
52-Wk Change:
133.82%

Stock Predictions

  • Is TG Therapeutics stock public?
    Yes, TG Therapeutics is a publicly traded company.
  • What is the TG Therapeutics stock quote today?
    The TG Therapeutics stock price is 25.86 USD today.
  • How to buy TG Therapeutics stock online?
    You can buy TG Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-16 24.57 24.50 24.86 24.05
Oct-18 23.97 23.31 24.23 23.13
Oct-21 23.06 24.39 24.41 22.85
Oct-22 24.27 24.25 24.66 23.66
Oct-23 24.12 23.13 24.28 23.00
Oct-24 23.20 23.22 23.38 22.61
Oct-25 23.26 23.36 24.31 23.22
Oct-28 23.67 24.35 24.57 23.41
Oct-29 26.02 25.71 26.23 24.35
Oct-30 25.66 25.14 25.78 24.78
Oct-31 25.06 25.06 25.40 24.23
Nov-1 25.28 26.90 26.99 25.14
Nov-4 24.39 24.45 25.05 22.92
Nov-5 24.49 25.86 26.02 23.60

TG Therapeutics Earnings

TG Therapeutics Earnings Report: Per Share TG Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

TG Therapeutics Forecast Revenue Growth

TG Therapeutics Stock Analysis: Historical quarterly revenues per share for TG Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.71 per share.

* TG Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.